These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3439519)

  • 1. Dihydrotachysterol and calcitriol in long-term dialyzed patients with renal bone disease.
    Wilczek H; Stĕpán J; Pacovský V
    Acta Univ Carol Med (Praha); 1986; 32(5-6):339-43. PubMed ID: 3439519
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings: Dihydrotachysterol in the treatment of bone abnormality in patients with renal failure undergoing chronic hemodialysis.
    Suda A; Ota K; Shirasu H
    Calcif Tissue Res; 1974; 15(2):159-60. PubMed ID: 4844399
    [No Abstract]   [Full Text] [Related]  

  • 3. Arrest of hyperparathyroid bone disease by the use of dihydrotachysterol in patients undergoing chronic hemodialysis.
    Kaye M; Chatterjee G; Cohen GF; Borra S; Sagar S
    Trans Assoc Am Physicians; 1970; 83():245-53. PubMed ID: 5505392
    [No Abstract]   [Full Text] [Related]  

  • 4. Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.
    Kliger AS; Yap P; Jensen P; Finkelstein FO
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():184-90. PubMed ID: 1029884
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term low-dose calcitriol treatment in predialysis chronic renal failure: can it prevent hyperparathyroid bone disease?
    Nordal KP; Dahl E; Halse J; Attramadal A; Flatmark A
    Nephrol Dial Transplant; 1995; 10(2):203-6. PubMed ID: 7753453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hydroxylated metabolites of vitamin D. Therapeutic use of calcitriol and dihydrotachysterol].
    Stĕpán J; Lachmanová J; Wilczek H; Straková M; Zichová M; Horn V; Tomásek R; Pacovský V
    Cas Lek Cesk; 1985 Dec; 124(50):1550-6. PubMed ID: 3841297
    [No Abstract]   [Full Text] [Related]  

  • 7. Early therapy of renal bone disease with calcitriol: a prospective double-blind study.
    Baker LR; Abrams SM; Roe CJ; Faugere MC; Fanti P; Subayti Y; Malluche HH
    Kidney Int Suppl; 1989 Nov; 27():S140-2. PubMed ID: 2699994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators.
    Chan JC; McEnery PT; Chinchilli VM; Abitbol CL; Boineau FG; Friedman AL; Lum GM; Roy S; Ruley EJ; Strife CF
    J Pediatr; 1994 Apr; 124(4):520-8. PubMed ID: 8151464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of hemodialysis bone disease with 24,25-(OH)2D3 and 1,25-(OH)2D3 alone or in combination.
    Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Eade Y; Johnson JR; George CR; Collett P
    Miner Electrolyte Metab; 1985; 11(6):358-68. PubMed ID: 3877862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention and therapy of regulatory hyperparathyroidism in kidney patients].
    Koall W; Mampel E; Hintner I; Kokot F
    Z Gesamte Inn Med; 1982 Apr; 37(7):197-201. PubMed ID: 7048771
    [No Abstract]   [Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal response to intermittent calcitriol therapy in secondary hyperparathyroidism.
    Salusky IB; Goodman W
    Kidney Int Suppl; 1996 Jan; 53():S135-9. PubMed ID: 8771008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serum alkaline phosphatases as an indicator of liver and bone disease in chronically dialyzed patients].
    Stĕpán J; Pilarová T; Votrubová O; Melicharová D
    Cas Lek Cesk; 1974 Aug; 113(31):952-7. PubMed ID: 4410849
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
    Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
    Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of extrarenal complications of chronic renal insufficiency in patients treated by peritoneal dialysis].
    Simon P
    Nephrologie; 1995; 16(1):77-83. PubMed ID: 7700424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Effect of dihydrotachysterol on azotemic renal osteodystrophy.
    Kawaguchi Y; Sakai S; Ogura Y; Kimura Y; Yamamoto M
    Calcif Tissue Res; 1974; 15(2):160. PubMed ID: 4844400
    [No Abstract]   [Full Text] [Related]  

  • 19. [Osteopathy in long-term dialysis. Diagnostic parameters and pathogenetic factors].
    Ritz E; Krempien N; Andrassy K
    Verh Dtsch Ges Inn Med; 1972; 78():1456-9. PubMed ID: 4665582
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol.
    Hymes LC; Warshaw BL
    Am J Dis Child; 1984 Dec; 138(12):1125-8. PubMed ID: 6548870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.